Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Critical Reviews in Oncology/Hematology
|
December 14, 2020
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
Pietro Lapidari, Ines Vaz-Luis, Antonio Di Meglio
Vaccine
|
February 4, 2024
Genomic and transcriptomic analysis of the recent Mpox outbreak
Federico M Giorgi, Daniele Pozzobon, Antonio Di Meglio, et al.
Current Opinion in Oncology
|
August 30, 2021
Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy
Antonio Di Meglio, Davide Soldato, Daniele Presti, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 14, 2021
Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers
Ines Vaz-Luis, Prudence A Francis, Antonio Di Meglio, et al.
BMC Cancer
|
August 28, 2014
Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature
Antonio Di Meglio, Pier Vitale Nuzzo, Francesco Ricci, et al.
Tumori
|
June 6, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report
Carlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
Tumori
|
September 30, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report
Carlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Reply to S. Yang
Davide Soldato, Ines Vaz-Luis, Antonio Di Meglio, et al.
The Lancet Regional Health. Europe
|
September 24, 2025
Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies
Hugo Jourdain, Antonio Di Meglio, Imène Mansouri, et al.
Oncology Research and Treatment
|
June 9, 2020
Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype
Elisa Zanardi, Antonio Di Meglio, Chiara Boccardo, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Critical Reviews in Oncology/Hematology
|
December 14, 2020
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
Pietro Lapidari, Ines Vaz-Luis, Antonio Di Meglio
Vaccine
|
February 4, 2024
Genomic and transcriptomic analysis of the recent Mpox outbreak
Federico M Giorgi, Daniele Pozzobon, Antonio Di Meglio, et al.
Current Opinion in Oncology
|
August 30, 2021
Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy
Antonio Di Meglio, Davide Soldato, Daniele Presti, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 14, 2021
Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers
Ines Vaz-Luis, Prudence A Francis, Antonio Di Meglio, et al.
BMC Cancer
|
August 28, 2014
Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature
Antonio Di Meglio, Pier Vitale Nuzzo, Francesco Ricci, et al.
Tumori
|
June 6, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report
Carlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
Tumori
|
September 30, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report
Carlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Reply to S. Yang
Davide Soldato, Ines Vaz-Luis, Antonio Di Meglio, et al.
The Lancet Regional Health. Europe
|
September 24, 2025
Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies
Hugo Jourdain, Antonio Di Meglio, Imène Mansouri, et al.
Oncology Research and Treatment
|
June 9, 2020
Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype
Elisa Zanardi, Antonio Di Meglio, Chiara Boccardo, et al.
Page
of 9